Basic Information
Fuisz Technologies Ltd. is a family-held company with broad technological interests and a long-standing, proven track record of innovation, including major (over $1 billion) product launches for large and specialty pharmaceutical companies as well as global consumer goods companies. The company played a key role in establishing the oral disintegrating tablet dosage form, the oral thin film dosage form, and made significant contributions to controlled drug release systems. Fuisz Technologies has extensive expertise in drug delivery systems, opioid abuse deterrence, and respiratory diagnostics. The company also has strong development initiatives in next-generation tobacco products and medical cannabis.